Category : Healthcare and Pharmaceuticals | Published at : January-2019 | Delivery Format : PDF | Status: Published | Pages : 160
Introduction
The global DNA and gene chip market size is projected to reach around USD 11.4 bn by 2026, with registered CAGR of 10.5% over the forecast period 2019 to 2026. The growth is driven by an increase in medical investment on R&D.
Market Dynamics
DNA and gene chips have increased much achievement in giving high throughput abilities to thorough genome concentrates to upgrade malady information and target them. This innovation has risen as an important and promising arrangement crosswise over different parts of illness the executives. These variables have been driving the DNA and gene chips market.
Constant improvement of new apparatuses to help and upgrade dependability of DNA microarray innovation is probably going to drive this market at a noteworthy pace within a reasonable time-frame. Moreover, social insurance elements are occupied with misusing novel answers for improving and joining information created from gene chip with information produced from high throughput innovations. Commonly gainful associations between microarray engineers and pharmaceutical/biopharmaceutical organizations for speeding up of genomic and biomedical research exercises is foreseen to goad showcase development in the coming years.
Market Insights
Traditional methods for gene examination permit examination of generally little measures of qualities at once, which further accentuates on the take-up of DNA microarray innovation. DNA microarray innovation permits the simultaneous examination of huge quantities of nucleic corrosive sections in a solitary trial.
Constant improvement of new apparatuses to help and upgrade dependability of DNA microarray innovation is probably going to drive this market at a noteworthy pace within a reasonable time-frame. Moreover, social insurance elements are occupied with misusing novel answers for improving and joining information created from gene chip with information produced from high throughput innovations. Commonly gainful associations between microarray engineers and pharmaceutical/biopharmaceutical organizations for speeding up of genomic and biomedical research exercises is foreseen to goad showcase development in the coming years.
Market Segmentation
Market By Application
- Cancer Diagnosis & Treatment
- Gene Expression
- Genotyping
- Genomics
- Drug Discovery
- Agricultural Biotechnology
- Others
Market By Product
- Consumables
- Instrumentation
Market By End-user
- Academic & Government Research Institutes
- Hospitals & Diagnostics Centers
- Biotechnology & Pharmaceutical Companies
- Others
Market By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of Asia-Pacific
- Latin America
- Brazil
- Chile
- Rest of Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of MEA
Regional Insights
The North America showcase caught the largest market share, for example, nearness of entrenched players, propelled informatics framework, nearness of specialists and gifted workforce, and continuous genomic R and D rehearses on a vast scale in the district.
Asia Pacific is relied upon to rise as a promising business sector, enlisting the most noteworthy CAGR over the conjecture time frame because of rising research and development demand in genomic examine. Besides, developing mindfulness with respect to hereditary tests for malady hazard evaluation and aversion is foreseen to positively affect the development of the regional market.
Market Participants
Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. The major players associated with the DNA and gene chip are bioMérieux SA, Thermo Fisher Scientific, Inc. (Affymetrix, Inc.), Savyon Diagnostics, Agilent Technologies, Applied Micro Arrays, Illumina, Inc., HOKUTO ELECTRONICS CORPORATION, TOSHIBA, Perkin Elmer, Inc., Oxford Gene Technology, Arrayit Corporation, MYcroarray, Macrogen Inc., Greiner Bio One International GmbH, Asper Biotech, CapitalBio Corporation, and Microarrays Inc.
Frequently Asked Questions
According to Acumen Research and Consulting, the global DNA and gene chip market size is projected to reach around USD 11.4 bn by 2026.
The global DNA and gene chip market size is expected to registered growth at a CAGR of 10.5% over the forecast period 2019 to 2026.
In 2018 the North America showcase caught the largest market share for DNA and gene chip market.
The major players associated with the DNA and gene chip market are bioMérieux SA, Thermo Fisher Scientific, Inc. (Affymetrix, Inc.), Savyon Diagnostics, Agilent Technologies, Applied Micro Arrays, Illumina, Inc., HOKUTO ELECTRONICS CORPORATION, TOSHIBA, and Perkin Elmer, Inc.
The application segments of DNA and gene chip market are Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology and Others
There are two types of products segment of DNA and gene chip market are consumables and instrumentation.
The regions covered in the DNA and gene chip market report such as North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa (MEA).
